DUR Board Quarterly Meeting

July 17, 2003
9:00 AM, Boise, ID

1. Welcome and Introductions – V. Culbertson / T. Eide
2. Approval of minutes from April meeting – R. Ting
3. Quarterly report on staff action since last meeting – V. Culbertson
4. Follow-up of 1st Quarter Intervention Studies – V. Culbertson
   1. Asthma module: Beta agonist overuse without corticosteroid
   2. Asthma module: Salmeterol use without corticosteroid
   3. Hormone replacement therapy
   4. ACE Inhibitor use in diabetic patients
5. Interventions and Therapeutic Category Assessments
   1. Acetaminophen Safety – B. Novak
   2. Appropriate Antimicrobial Use: Acute Sinusitis – B. Novak
   3. Statin Noncompliance – R. Force
6. Proposed Interventions and Therapeutic Category Assessments
   1. Metformin / Glitazone Safety – Tracy Pettinger
   2. Underutilization/Sub-therapeutic Dose of ACEI in CHF – C. Owens
   3. Underutilization of Statins in Secondary Prevention – V. Culbertson
7. Re-visit of By-laws – T. Eide
8. Medicaid Update – T. Eide
9. Other business
10. Meeting dates
    1. Boise - October 16, 2003
    2. Pocatello - January 15, 2004